<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">

ADVISORY BOARD

Who are the executives providing leadership, support and strategic advice on the mission of Biotech and Money

JOIN ADVISORY BOARD

ADVISORY BOARD

DEBRA AINGE COO CLINIGEN

Debra Ainge

CCO, Clinigen

WILL ARENDS Pattent Attorney MARKS & CLERK

Will Arends

Patent Attorney, Marks & Clerk

PAUL ASHLEY Head of Technology Transfer, Life Sciences OXFORD UNIVERSITY INNOVATION LTD.

Paul Ashley

Head of Technology Transfer, Life Sciences Oxford University Innovation LTD.

TINA BAKER Partner JAG SHAW BAKER

Tina Baker

Partner, Jag Shaw Baker

VIJAY BARATHAN Life Science Partner CATAPULT VENTURES

Vijay Barathan

Life Science Partner, Catapult Ventures

LAURENCE BARKER CBO DEMENTIA DISCOVERY FUND, SV LIFE SCIENCES

Laurence Barker

CBO, Dementia Discovery Fund, SV Life Sciences

Mary-Jane Elliott co-founded Consilium Strategic Communications after leading the MBO from M:Communications in 2013. She possesses almost 20 years of ...

Read More

Mary-Jane Elliott co-founded Consilium Strategic Communications after leading the MBO from M:Communications in 2013. She possesses almost 20 years of experience from leading financial PR agencies and industry roles. Before founding Consilium, Mary-Jane led M:Communications’ international healthcare team. Prior to that she was a Partner within WPP’s Buchanan Communications’ healthcare team. She has a broad range of experience across international capital markets. Mary-Jane spent six years working at PowderJect Pharmaceuticals Plc, initially as a scientist and latterly in investor relations and corporate communications, prior to the acquisition by Chiron Corporation. She started her career at Bell Laboratories Inc in Madison, Wisconsin US. As a healthcare specialist, she has a BSc (Hons) in BioMedical Sciences.

ALEX BENNETT CEO THE RSA GROUP

Alex Bennett

CEO, The RSA Group

KATE BINGHAM Managing Partner SV HEALTH INVESTORS

Kate Bingham

Managing Partner, SV Health Investors

CHRIS BLACKWELL Director PROMENTRA

Chris Blackwell

Director, Promentra

KEITH BLUNDY CEO STORM THERAPEUTICS

Keith Blundy

CEO, Storm Therapeutics

PHILIP BROKE Partner WHITE & CASE

Philip Broke

Partner, White & Case

CLAIRE BROWN Investment Manager ALDERLEY PARK VENTURES

Claire Brown

Investment Manager, Alderley Park Ventures

SUE CHARLES Managing Partner, Life Sciences INSTINCTIF PARTNERS

Sue Charles

Managing Partner Life Sciences, Instinctif Partners

PAUL CLAYDON PARTNER COVINGTON AND BURLING

Paul Claydon

Partner, Covington and Burling

SIMON CONWAY Partner FTI CONSULTING

Simon Conway

Partner, FTI Consulting

MICK COOPER Healthcare and Life Sciences Analyst TRINITY DELTA

Mick Cooper

Healthcare and Life Sciences Analyst, Trinity Delta

MARK COURT Partner BUCHANAN

Mark Court

Partner, Buchanan

MICHEL DE BAAR Executive Director BD&L MSD

Michel De Baar

Executive Director BD&L, MSD

FRANCESCO DE RUBERTIS Managing Partner MEDICXI

Francesco De Rubertis

Managing Partner, Medicxi

PETER DINES Life Science Entrepreneur and Investor MERCIA TECHNOLOGIES

Peter Dines

Life Science Entrepreneur and Investor, Mercia Technologies

MARY-JANE ELLIOTT Managing Partner CONSILIUM STRATEGIC COMMUNICATIONS

Mary-Jane Elliott

Managing Partner, Consilium Strategic Communications

Keith joined CRT in 1998, became COO in 2004 and was appointed CEO in 2007. Since then he has overseen the launch of a £50m Cancer Research Technology...

Read More

Keith joined CRT in 1998, became COO in 2004 and was appointed CEO in 2007. Since then he has overseen the launch of a £50m Cancer Research Technology Pioneer Fund in partnership with the European Investment Fund (EIF) to bridge the UK funding gap between cancer drug discovery and early treatment development. He has initiated risk sharing discovery alliances with AstraZeneca and Teva (formerly Cephalon), the establishment of CRT Inc in Boston (USA) as a business development arm of CRT and the further globalisation of CRT’s cancer IP development and commercialisation through becoming a partner of Cancer Therapeutics Pty in Melbourne, Australia.

SAM FAZELI Head of Bloomberg Intelligence BLOOMBERG

Sam Fazeli

Head of Intelligence, Bloomberg

ISOBEL FINNIE Patent Attorney HASELTINE LAKE LLP

Isobel Finnie

Patent Attorney, Haseltine Lake LLp

NIGEL GAYMOND Advisory Board BRITISH EXPATS IN LIFE SCIENCES

Nigel Gaymond

Advisory Board, British Expats in Life Science

clinigen_chief_executive_peter_george-1.jpg

peter george

Non-Executive Director, Clinigen

Keith joined CRT in 1998, became COO in 2004 and was appointed CEO in 2007. Since then he has overseen the launch of a £50m Cancer Research Technology...

Read More

KEITH BLUNDY

Keith joined CRT in 1998, became COO in 2004 and was appointed CEO in 2007. Since then he has overseen the launch of a £50m Cancer Research Technology Pioneer Fund in partnership with the European Investment Fund (EIF) to bridge the UK funding gap between cancer drug discovery and early treatment development. He has initiated risk sharing discovery alliances with AstraZeneca and Teva (formerly Cephalon), the establishment of CRT Inc in Boston (USA) as a business development arm of CRT and the further globalisation of CRT’s cancer IP development and commercialisation through becoming a partner of Cancer Therapeutics Pty in Melbourne, Australia.

HAKAN GOKER Senior Investment Director MERCK VENTURES

Hakan Goker

Senior Investment Director, Merck Ventures

MELANIE GOWARD Investment Director MAVEN CAPITAL PARTNERS UK LLP

Melanie Goward

Investment Director, Maven Capital Partners UK

SHAUN GRADY Vice President - Strategic Partnering & Business Development ASTRAZENECA

Shaun Grady

VP Strategic Partnering & Business Development, Astrazeneca

CONOR GRIFFIN Managing Director HUME BROPHY

Conor Griffin

Managing Director, Hume Brophy

GARY GREEN Partner CMS CAMERON MCKENNA

Gary Green

Partner, CMS Cameron Mckenna

SARAH HANSON Head of CMS Commercial Law Group CMS CAMERON MCKENNA

Sarah Hanson

Head of CMS Commercial Law Group, CMS Cameron Mckenna

DEBORAH HARLAND Partner SR ONE

Deborah Harland

Partner, SR One

TIMOTHY HERPIN Vice-President, Strategic Partnering & Business Development, Oncology & STL ASTRAZENECA

Timothy Herpin

VP Strategic Partnering & Business Development, Astrazeneca

TONY HICKSON Managing Director, Technology Transfer, IMPERIAL INNOVATIONS

Tony Hickson

Managing Director & Technology Transfer, Imperial Innovations

ASAF HOMOSSANY Managing Director, EMEA NASDAQ

Asaf Homossany

Managing Director EMEA, NASDAQ

VIVIANE JOYNES Managing Director EQS

Viviane Joynes

Managing Director, EQS

STEFAN KECMAN Associate WHITE & CASE LLP

Stefan Kecman

Associate, White & Case LLP

LIZ KLEIN CEO KLEIN- EDMONDS ASSOCIATES

LIz Klein

CEO, Klein-Edmonds Associates

OLGA KRYLOVA Senior Director PFIZER

Olga Krylova

Senior Director, Pfizer

LUIGI LA CORTE Head of WWBD GSK

Luigi La Corte

Head of WWBD, GSK

PHIL L'HUILLIER Director CRT

Phil L'Huillier

Director, CRT

TIM LUKER Director External Innovation, Global External R&D LILLY

Tim Luker

Director External Innovation & Global External R&D, Eli Lilly and Company

DAVID MACMURCHY Head of Life Sciences EY

David Macmurchy

Head of Life Science, EY

GIOVANNI MARIGGI Principal MEDICXI

Giovanni Mariggi

Principal, Medicxi

FRANCOIS MARTELET Group CEO NETSCIENTIFIC

Francois Martelet

Group CEO, Netscientific

SOPHIE MCGRATH Partner BROWN RUDNICK

Sophie McGrath

Partner, Brown Rundnick

CHRIS MOLLOY CEO MEDICINES DISCOVERY CATAPULT

Chris Molloy

CEO, Medicines Discovery Catapult

NICHOLAS MOORE SVP JEFFERIES

Nicholas Moore

SVP, Jefferies

DANIEL OLIVER Director CAPITAL CELL

Daniel Oliver

Director, Capital Cell

PETER PACK CEO CRESCENDO BIOLOGICS LTD

Peter Pack

CEO, Crescendo Biologics LTD

JO PISANI Global Pharmaceuticals and Life Sciences Advisory Leader PWC

Jo Pisani

Global Pharmaceuticals and Life Sciences Advisory Leader, PWC

NIGEL PITCHFORD CIO TOUCHSTONE INNOVATIONS

Nigel Pitchford

CIO, Touchstone Innovations

KEITH POWELL Chairman DOMAINEX

Keith Powell

Chairman, Domainex

ALEXANDRA PYGALL Partner STEPHENSON HARWOOD

Alexandra Pygall

Partner, Stephenson Harwood

ANDY RICHARDS Member of the Advisory Board CAMBRIDGE INNOVATION CAPITAL

Andy Richards

Member of the Advisory Board, Cambridge Innovation Capital

RYAN RICHARDSON Vice President JP MORGAN

Ryan Richardson

VP, JP Morgan

ALAN ROBSON Relationship Director Healthcare BARCLAYS

Alan Robson

Relationship Director Healthcare, Barclays

CHRISTOPH RUEDIG Partner ALBION VENTURES

Christoph Ruedig

Partner, Albion Ventures

RICHARD SEABROOK Head of Business Development WELLCOME TRUST

Richard Seabrook

Head of Business Development, Wellcome Trust

JULIE SIMMONDS Director of Equity Research PANMURE GORDON

Julie Simmonds

Director of Equity Research, Panmure Gordon

MARK SWALLOW Senior Director CITIGATE DEWE ROGERSON

Mark Swallow

Senior Director, Citigate Dewe Rogerson

IAIN THOMAS Head of Life Sciences CAMBRIDGE ENTERPRISE

Iain Thomas

Head of Life Sciences, Cambridge Enterprise

BEN THORPE Co-Head of EMEA Healthcare GOLDMAN SACHS

Ben Thorpe

Co-head of EMEA Healthcare, Goldman Sachs

JONATHAN TOBIN Investment Manager ARIX BIOSCIENCE PLC

Jonathan Tobin

Investment Manager, Arix Bioscience PLC

PAUL TOMASIC Managing Director, European Head of Healthcare RBC CAPITAL

Paul Tomasic

Managing Director European Head of Healthcare, RBC Capital

IAN TOMLINSON CEO APOLLO THERAPEUTICS

Ian Tomlinson

CEO, Apollo Therapeutics

SIMON TURNER Managing Partner ALACRITA

Simon Turner

Managing Partner, Alacrita

ANTHONY WALKER Managing Partner ALACRITA

Anthony Walker

Managing Partner, Alacrita

MELANIE WEST Consultant ODGERS BERNDTSON

Melanie West

Consultant, Odgers Berndtson

LAUREN WILLIAMS Managing Director TROUT INTERNATIONAL

Lauren Williams

Managing Director, Trout International

MIKE WORT Senior Associate WALBROOK PR

Mike Wort

Senior Associate, Walbrook PR

JOIN ADVISORY BOARD
Alacrita
allen and overy
Appleyard Lees
barclays
Boult Wade Tennant
Cancer Research UK.jpg
capitalcell.png
CMS Cameron Mckenna.png
covington.png
eqs.png
gje.png
Gallagher.png
Horizon.png
Inceptua
Marks & Clerk Intellectual Property Services.jpeg
Xplico.png